Felix Hesselmann

Felix Hesselmann

Auto-generated profile, based on publicly available information

Felix Hesselmann

Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University, Aachen, Germany

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2021 in Journal of Membrane Science
Verified
Journal Article
Closed access
FHFelix Hesselmann
Felix Hesselmann
NSNils Scherenberg
Nils Scherenberg
PBPatrick Bongartz
Patrick Bongartz
SDSuzana Djeljadini
Suzana Djeljadini
MWMatthias Wessling
Matthias Wessling
Jutta ArensJutta Arens
Jutta Arens

3 May 2022 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FHFelix Hesselmann
Felix Hesselmann
MHMichael Halwes
Michael Halwes
PBPatrick Bongartz
Patrick Bongartz
MWMatthias Wessling
Matthias Wessling
CCChristian Cornelissen
Christian Cornelissen
JAJutta Arens
Jutta Arens
Membrane lungs consist of thousands of hollow fiber membranes packed together as a bundle. The devices often suffer from complications because of non-uniform flow through the membrane bundle, including regions of both excessively high flow and stagnant flow. Here, we present a proof-of-concept design for a membrane lung containing a membrane module based on triply periodic minimal surfaces (TPMS). By warping the original TPMS geometries, the local permeability within any region of the module could be raised or lowered, allowing for the tailoring of the blood flow distribution through the device. By creating an iterative optimization scheme for determining the distribution of streamwise permeability inside a computational porous domain, the desired form of a lattice of TPMS elements was determined via simulation. This desired form was translated into a computer-aided design (CAD) model for a prototype device. The device was then produced via additive manufacturing in order to test the novel design against an industry-standard predicate device. Flow distribution was verifiably homogenized and residence time reduced, promising a more efficient performance and increased resistance to thrombosis. This work shows the promising extent to which TPMS can serve as a new building block for exchange processes in medical devices.

21 June 2021 in Bio-Design and Manufacturing
Verified
Journal Article
Open access
PDF file
FHFelix Hesselmann
Felix Hesselmann
JFJannis Mathias Focke
Jannis Mathias Focke
PSPeter C. Schlanstein
Peter C. Schlanstein
NSNiklas Steuer
Niklas Steuer
AKAndreas Kaesler
Andreas Kaesler
Jutta ArensJutta Arens
Jutta Arens
Currently, artificial-membrane lungs consist of thousands of hollow fiber membranes where blood flows around the fibers and gas flows inside the fibers, achieving diffusive gas exchange. At both ends of the fibers, the interspaces between the hollow fiber membranes and the plastic housing are filled with glue to separate the gas from the blood phase. During a uniaxial centrifugation process, the glue forms the “potting.” The shape of the cured potting is then determined by the centrifugation process, limiting design possibilities and leading to unfavorable stagnation zones associated with blood clotting. In this study, a new multiaxial centrifugation process was developed, expanding the possible shapes of the potting and allowing for completely new module designs with potentially superior blood flow guidance within the potting margins. Two-phase simulations of the process in conceptual artificial lungs were performed to explore the possibilities of a biaxial centrifugation process and determine suitable parameter sets. A corresponding biaxial centrifugation setup was built to prove feasibility and experimentally validate four conceptual designs, resulting in good agreement with the simulations. In summary, this study shows the feasibility of a multiaxial centrifugation process allowing greater variety in potting shapes, eliminating inefficient stagnation zones and more favorable blood flow conditions in artificial lungs. Graphic abstract

4 October 2021 in Artificial Organs
Verified
Journal Article
Open access
PDF file
FHFelix Hesselmann
Felix Hesselmann
DADaniel Arnemann
Daniel Arnemann
PBPatrick Bongartz
Patrick Bongartz
MWMatthias Wessling
Matthias Wessling
CCChristian Cornelissen
Christian Cornelissen
Jutta ArensJutta Arens
Jutta Arens
Background: Membranes based on triply periodic minimal surfaces (TPMS) have proven a superior gas transfer compared to the contemporary hollow fiber membrane (HFM) design in artificial lungs. The improved oxygen transfer is attributed to disrupting the laminar boundary layer adjacent to the membrane surface known as main limiting factor to mass transport. However, it requires experimental proof that this improvement is not at the expense of greater damage to the blood. Hence, the aim of this work is a valid statement regarding the structure‐dependent hemolytic behavior of TPMS structures compared to the current HFM design.Methods: Hemolysis tests were performed on structure samples of three different kind of TPMS‐based designs (Schwarz‐P, Schwarz‐D and Schoen’s Gyroid) in direct comparison to a hollow fiber structure as reference.Results: The results of this study suggest that the difference in hemolysis between TPMS membranes compared to HFMs is small although slightly increased for the TPMS membranes. There is no significant difference between the TPMS structures and the hollow fiber design. Nevertheless, the ratio between the achieved additional oxygen transfer and the additional hemolysis favors the TPMS‐based membrane shapes.Conclusion: TPMS‐shaped membranes offer a safe way to improve gas transfer in artificial lungs.

31 March 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
LSLasse Johannes Strudthoff
Lasse Johannes Strudthoff
JFJannis Mathias Focke
Jannis Mathias Focke
FHFelix Hesselmann
Felix Hesselmann
AKAndreas Kaesler
Andreas Kaesler
ACAna Martins Costa
Ana Martins Costa
SJSebastian Victor Jansen
Sebastian Victor Jansen
The overall survival rate of extracorporeal life support (ECLS) remains at 60%. Research and development has been slow, in part due to the lack of sophisticated experimental models. This publication introduces a dedicated rodent oxygenator (“RatOx”) and presents preliminary in vitro classification tests. The RatOx has an adaptable fiber module size for various rodent models. Gas transfer performances over the fiber module for different blood flows and fiber module sizes were tested according to DIN EN ISO 7199. At the maximum possible amount of effective fiber surface area and a blood flow of 100 mL/min, the oxygenator performance was tested to a maximum of 6.27 mL O2/min and 8.2 mL CO2/min, respectively. The priming volume for the largest fiber module is 5.4 mL, while the smallest possible configuration with a single fiber mat layer has a priming volume of 1.1 mL. The novel RatOx ECLS system has been evaluated in vitro and has demonstrated a high degree of compliance with all pre-defined functional criteria for rodent-sized animal models. We intend for the RatOx to become a standard testing platform for scientific studies on ECLS therapy and technology.

7 December 2016 in Cellular and Molecular Bioengineering
Verified
Journal Article
Closed access
PDF file
TPTobias Plein
Tobias Plein
ATAnja Lena Thiebes
Anja Lena Thiebes
NFNicole Finocchiaro
Nicole Finocchiaro
FHFelix Hesselmann
Felix Hesselmann
TSThomas Schmitz-Rode
Thomas Schmitz-Rode
CCChristian G. Cornelissen
Christian G. Cornelissen